Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial - Concepedia

Concepedia

Publication | Open Access

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

DOI Full Paper Access

93

Citations

17

References

2022

Year

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne Flem Jacobsen, Anette Tarp Hansen, Marc Rodger,

Abstract

French Ministry of Health, Health Research Board Ireland, GSK/Aspen, and Pfizer.

References

	Year	Citations

Page 1